Electronic submission of eCTD to become mandatory for EU centralized procedure
This article was originally published in SRA
Executive Summary
From 1 March 2014, pharmaceutical companies filing an electronic market authorization application via the EU centralized procedure must do so using the European Medicines Agency's eSubmission Gateway or the agency's eSubmission web client1.